Literature DB >> 18538739

Further evidence for expression and function of the VEGF-C/VEGFR-3 axis in cancer cells.

Jen-Liang Su, Pai-Sheng Chen, Ming-Hsien Chien, Poshen B Chen, Ya-Huey Chen, Chien-Chen Lai, Mien-Chie Hung, Min-Liang Kuo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18538739     DOI： 10.1016/j.ccr.2008.04.021

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


× No keyword cloud information.
  18 in total

1.  Vascular endothelial growth factor-C promotes the growth and invasion of gallbladder cancer via an autocrine mechanism.

Authors:  Yanling Chen; Lei Jiang; Feifei She; Nanhong Tang; Xiaoqian Wang; Xiujin Li; Shenghua Han; Jinhai Zhu
Journal:  Mol Cell Biochem       Date:  2010-08-25       Impact factor: 3.396

2.  An orally administered DNA vaccine targeting vascular endothelial growth factor receptor-3 inhibits lung carcinoma growth.

Authors:  Yan Chen; Xin Liu; Cong Guo Jin; Yong Chun Zhou; Roya Navab; Kristine Raaby Jakobsen; Xiao Qun Chen; Jia Li; Ting Ting Li; Lu Luo; Xi Cai Wang
Journal:  Tumour Biol       Date:  2015-09-16

3.  Lymphangioleiomyoma cells and lymphatic endothelial cells: expression of VEGFR-3 in lymphangioleiomyoma cell clusters.

Authors:  Kuniaki Seyama; Keiko Mitani; Toshio Kumasaka; Shiv K Gupta; Saji Oommen; Gang Liu; Jay H Ryu; Nicholas E Vlahakis
Journal:  Am J Pathol       Date:  2010-03-04       Impact factor: 4.307

4.  Neutralizing endogenous VEGF following traumatic spinal cord injury modulates microvascular plasticity but not tissue sparing or functional recovery.

Authors:  Richard L Benton; Melissa A Maddie; Mark J Gruenthal; Theo Hagg; Scott R Whittemore
Journal:  Curr Neurovasc Res       Date:  2009-05       Impact factor: 1.990

5.  VEGFR3: a new target for antiangiogenesis therapy?

Authors:  Timothy P Padera; Rakesh K Jain
Journal:  Dev Cell       Date:  2008-08       Impact factor: 12.270

6.  Small molecule chloropyramine hydrochloride (C4) targets the binding site of focal adhesion kinase and vascular endothelial growth factor receptor 3 and suppresses breast cancer growth in vivo.

Authors:  Elena V Kurenova; Darell L Hunt; Dihua He; Andrew T Magis; David A Ostrov; William G Cance
Journal:  J Med Chem       Date:  2009-08-13       Impact factor: 7.446

7.  Vascular endothelial growth factor receptor-3 promotes breast cancer cell proliferation, motility and survival in vitro and tumor formation in vivo.

Authors:  Elena V Kurenova; Darrell L Hunt; Dihua He; Ann D Fu; Nicole A Massoll; Vita M Golubovskaya; Christopher A Garces; William G Cance
Journal:  Cell Cycle       Date:  2009-07-23       Impact factor: 4.534

8.  The extra domain A of fibronectin increases VEGF-C expression in colorectal carcinoma involving the PI3K/AKT signaling pathway.

Authors:  Lisha Xiang; Ganfeng Xie; Juanjuan Ou; Xing Wei; Feng Pan; Houjie Liang
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

9.  Expression and significances of contactin-1 in human gastric cancer.

Authors:  Ji-Wei Yu; Sheng-Hua Wu; Rui-Qi Lu; Ju-Gang Wu; Xiao-Chun Ni; Gou-Cai Zhou; Hai-Guang Jiang; Lin-Hai Zheng; Xiao-Qiang Li; Guang-Ye Du; Bo-Jian Jiang
Journal:  Gastroenterol Res Pract       Date:  2013-03-31       Impact factor: 2.260

Review 10.  The role of the VEGF-C/VEGFRs axis in tumor progression and therapy.

Authors:  Jui-Chieh Chen; Yi-Wen Chang; Chih-Chen Hong; Yang-Hao Yu; Jen-Liang Su
Journal:  Int J Mol Sci       Date:  2012-12-20       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.